NCT00866073View on ClinicalTrials.gov

Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Decitabine 15 mg/m2 i.v.

Decitabine at 15 mg/m2 i.v. x 3 hours, three times daily on three consecutive days

Trial Locations (8)

30625

Medizinische Hochschule Hannover, Hanover

Unknown

Klinikum der Technischen Universität Aachen, Aachen

Universitätsklinikum Düsseldorf, Düsseldorf

Katholisches Krankenhaus Hagen, Hagen

Klinikum Lüdenscheid, Lüdenscheid

Universitätsklinikum Ulm, Ulm

Klinikum Villingen-Schwenningen, Villingen-Schwenningen

Leyenburg Hospital, The Hague

All Listed Sponsors
lead

University Hospital Freiburg

OTHER

NCT00866073 - Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter